Symbicort was first FDA-approved in 2006 as a treatment for asthma, followed by an extension to its label covering COPD in 2009. A further approval in 2017 in childhood asthma has helped the drug ...

New data showed that using SYMBICORT® for asthma provides a rapid and clinically significant bronchodilatory response and improvement in lung function. New data showed that using SYMBICORT® for ...

namely maintenance treatment for asthma and chronic obstructive pulmonary disease (COPD). Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the ...

Formoterol (found in Symbicort, Dulera ... SABAs work quickly and are used to halt asthma attacks and other asthma symptoms ...